Bioleaders Corporation

11:45 AM - 12:00 PM, Tuesday, June 4, 2019 ・ Theater 4
Bioleaders Corporation is research-based, clinical stage, Biopharmaceutical company located in Korea. The mission of Bioleaders is to become a leader in developing innovative therapies that improve the lives of patients through inducing patients' immune systems for the treatment of transmissible infections and other serious afflictions such as cancer and rare diseases. A professional management team and an active advisory board members are uniquely suited, through technical and industrial experiences, to fulfill the Company’s mission to commercialize life-saving therapeutics and cultivate revenue-generating partnerships with companies in biotechnology and pharmaceuticals. Bioleaders' long-term plan is to establish strong intellectual properties and drug portfolios that will become a foundation for global partnerships.
Ticker:
142760
Exchange:
KOSDAQ
Company Type:
Company Website:
Company HQ State:
Not Provided.
Company HQ Country:
Korea - South Korea
Year Founded:
1999
Main Therapeutic Focus:
Lead Product in Development:
BLS-H01 (CIN 1 therapeutic agent)
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
3
Speaker
photo
Director
Bioleaders